Common Stock, Shares, Outstanding of VitaNova Life Sciences Corp from 30 Apr 2017 to 31 Oct 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
VitaNova Life Sciences Corp quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Apr 2017 to 31 Oct 2025.
  • VitaNova Life Sciences Corp Common Stock, Shares, Outstanding for the quarter ending 31 Oct 2025 was 25,012,270, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

VitaNova Life Sciences Corp Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 25,012,270 0 0% 31 Oct 2025 10-Q 15 Dec 2025 2026 Q2
Q2 2025 25,012,270 0 0% 31 Jul 2025 10-Q 12 Sep 2025 2026 Q1
Q1 2025 25,012,270 0 0% 30 Apr 2025 10-Q 15 Dec 2025 2026 Q2
Q4 2024 25,012,270 0 0% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 25,012,270 +19,141,020 +326% 31 Oct 2024 10-Q 13 Dec 2024 2025 Q2
Q2 2024 25,012,270 +19,141,020 +326% 31 Jul 2024 10-Q 10 Sep 2024 2025 Q1
Q1 2024 25,012,270 +19,141,020 +326% 30 Apr 2024 10-K 24 Jul 2025 2025 FY
Q4 2023 25,012,270 +19,141,020 +326% 31 Jan 2024 10-Q 11 Mar 2024 2024 Q3
Q3 2023 5,871,250 0 0% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q2
Q2 2023 5,871,250 0 0% 31 Jul 2023 10-Q 14 Sep 2023 2024 Q1
Q1 2023 5,871,250 0 0% 30 Apr 2023 10-K 29 Jul 2024 2024 FY
Q4 2022 5,871,250 0 0% 31 Jan 2023 10-Q 16 Feb 2023 2023 Q3
Q3 2022 5,871,250 0 0% 31 Oct 2022 10-Q 14 Nov 2022 2023 Q2
Q2 2022 5,871,250 0 0% 31 Jul 2022 10-Q 01 Sep 2022 2022 Q1
Q1 2022 5,871,250 0 0% 30 Apr 2022 10-K 15 May 2023 2023 FY
Q4 2021 5,871,250 0 0% 31 Jan 2022 10-Q 17 Feb 2022 2022 Q3
Q3 2021 5,871,250 0 0% 31 Oct 2021 10-Q 10 Nov 2021 2021 Q2
Q2 2021 5,871,250 0 0% 31 Jul 2021 10-Q 20 Aug 2021 2022 Q1
Q1 2021 5,871,250 0 0% 30 Apr 2021 10-K 16 May 2022 2022 FY
Q4 2020 5,871,250 0 0% 31 Jan 2021 10-Q 21 Jun 2021 2021 Q3
Q3 2020 5,871,250 0 0% 31 Oct 2020 10-Q 25 Nov 2020 2021 Q2
Q2 2020 5,871,250 0 0% 31 Jul 2020 10-Q 18 Sep 2020 2021 Q1
Q1 2020 5,871,250 0 0% 30 Apr 2020 10-K 01 Jul 2021 2021 FY
Q4 2019 5,871,250 0 0% 31 Jan 2020 10-Q 20 Mar 2020 2020 Q3
Q3 2019 5,871,250 0 0% 31 Oct 2019 10-Q 06 Dec 2019 2020 Q2
Q2 2019 5,871,250 0 0% 31 Jul 2019 10-Q 12 Sep 2019 2020 Q1
Q1 2019 5,871,250 0 0% 30 Apr 2019 10-K 05 Aug 2020 2020 FY
Q4 2018 5,871,250 0 0% 31 Jan 2019 10-Q 15 Mar 2019 2019 Q3
Q3 2018 5,871,250 31 Oct 2018 10-Q 18 Dec 2018 2019 Q2
Q2 2018 5,871,250 31 Jul 2018 10-Q 17 Aug 2018 2019 Q1
Q1 2018 5,871,250 +2,371,250 +68% 30 Apr 2018 10-K 30 Jul 2019 2019 FY
Q4 2017 5,871,250 31 Jan 2018 10-Q 22 Feb 2018 2018 Q3
Q1 2017 3,500,000 30 Apr 2017 10-K 17 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.